Cargando…

Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency

Evidence on the cost-effectiveness of newborn screening (NBS) for severe combined immunodeficiency (SCID) in the Australian policy context is lacking. In this study, a pilot population-based screening program in Australia was used to model the cost-effectiveness of NBS for SCID from the government p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shih, Sophy T. F., Keller, Elena, Wiley, Veronica, Wong, Melanie, Farrar, Michelle A., Chambers, Georgina M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326549/ https://www.ncbi.nlm.nih.gov/pubmed/35892474 http://dx.doi.org/10.3390/ijns8030044

Ejemplares similares

Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
por: Shih, Sophy T. F., et al.
Publicado: (2022)

Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)
por: van der Burg, Mirjam, et al.
Publicado: (2019)

A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK
por: Bessey, Alice, et al.
Publicado: (2019)

A Case of Severe Combined Immunodeficiency Missed by Newborn Screening
por: Kitcharoensakkul, Maleewan, et al.
Publicado: (2021)

A Call to Include Severe Combined Immunodeficiency in Newborn Screening Program
por: Somech, Raz, et al.
Publicado: (2014)

Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience
por: Heather, Natasha, et al.
Publicado: (2022)

Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2022)

Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program
por: Blom, Maartje, et al.
Publicado: (2018)

Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme
por: D'Silva, Arlene M, et al.
Publicado: (2021)

Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management
por: Dorsey, Morna, et al.
Publicado: (2017)

Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do?
por: Mongkonsritragoon, Wimwipa, et al.
Publicado: (2023)

TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review
por: van der Spek, Jet, et al.
Publicado: (2015)

First Year of Israeli Newborn Screening for Severe Combined Immunodeficiency—Clinical Achievements and Insights
por: Rechavi, Erez, et al.
Publicado: (2017)

A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening
por: Al Sukaiti, Nashat, et al.
Publicado: (2021)

Newborn Screening for Severe Combined Immunodeficiency: Do Preterm Infants Require Special Consideration?
por: Atkins, Anne E., et al.
Publicado: (2021)

Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening
por: Raspa, Melissa, et al.
Publicado: (2023)

Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data
por: van den Akker-van Marle, M. Elske, et al.
Publicado: (2021)

Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening
por: de Pagter, Anne P. J., et al.
Publicado: (2015)

NEWBORN SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCIES USING TRECS AND KRECS: SECOND PILOT STUDY IN BRAZIL
por: Kanegae, Marilia Pyles P., et al.
Publicado: (2017)

Development of a Population-Based Newborn Screening Method for Severe Combined Immunodeficiency in Manitoba, Canada
por: Thompson, J. Robert, et al.
Publicado: (2018)

Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases
por: Jilkina, O., et al.
Publicado: (2014)

“We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy
por: Kariyawasam, Didu S.T., et al.
Publicado: (2021)

Newborn Screening for Severe Combined Immunodeficiency Using the Multiple of the Median Values of T-Cell Receptor Excision Circles
por: Cogley, Michael F., et al.
Publicado: (2021)

IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY
por: Meehan, Cristina, et al.
Publicado: (2018)

Screening for severe combined immunodeficiency in neonates
por: Kelly, Brian T, et al.
Publicado: (2013)

A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay
por: Thakar, Monica S., et al.
Publicado: (2017)

First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain)
por: Argudo-Ramírez, Ana, et al.
Publicado: (2019)

Immunological Findings and Clinical Outcomes of Infants With Positive Newborn Screening for Severe Combined Immunodeficiency From a Tertiary Care Center in the U.S.
por: Mantravadi, Vasudha, et al.
Publicado: (2021)

Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme
por: Lai, Fei, et al.
Publicado: (2020)

Newborn Screening Samples for Diabetes Research: An Underused Resource
por: Estrella, Jane Frances Grace Lustre, et al.
Publicado: (2020)

Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
por: Strand, Janne, et al.
Publicado: (2020)

Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
por: Fazi, C., et al.
Publicado: (2022)

Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency
por: Blom, Maartje, et al.
Publicado: (2021)

Implementation of Universal Newborn Screening for Severe Combined Immunodeficiency in Singapore While Continuing Routine Bacille-Calmette-Guerin Vaccination Given at Birth
por: Chan, Su-Wan Bianca, et al.
Publicado: (2022)

Modern diagnostic capabilities of neonatal screening for primary immunodeficiencies in newborns
por: Khalturina, Evgenia Olegovna, et al.
Publicado: (2021)

Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden—a 2-Year Pilot TREC and KREC Screening Study
por: Barbaro, Michela, et al.
Publicado: (2016)

Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy: First Workshop Report: Establishing Australian health system readiness for the implementation and evaluation of a pilot program in New South Wales and the Australian Capital Territory
por: Farrar, Michelle A., et al.
Publicado: (2023)

Economic evaluation of newborn hearing screening: modelling costs and outcomes
por: Hessel, Franz, et al.
Publicado: (2003)

Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices
por: Knight, Vijaya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ka61ck2msf598ledfjipa11uj